ANIX - EXCLUSIVE: Anixa Biosciences Finds Stock Undervalued Launches $5M Stock Buyback Program | Benzinga
Anixa Biosciences, Inc (NASDAQ:ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that its Board of Directors has authorized a share repurchase program of up to $5 million of the company's outstanding common stock.
"We believe that Anixa's stock is currently undervalued, and this program provides an opportunity to enhance long-term shareholder value," stated Dr. Amit Kumar, Chairman and CEO ...